Results 41 to 50 of about 1,474,310 (169)
DiagnosticsBackground: Interleukin-10 (IL-10) and vascular endothelial growth factor (VEGF) are believed to possess a role in the pathophysiology of multiple myeloma (MM).
Fulya Memis +4 more
doaj +1 more source
Allergology International, 2010 As the key molecule of type-I-hypersensitivity, IgE provides specificity for the allergen and links it to the allergic effector functions. Antibodies are secreted by plasma cells and their precursors, the plasma blasts.
Elke O. Luger +5 more
doaj +1 more source
Frontiers in Immunology, 2023 IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B ...
Byunghyun Park +8 more
doaj +1 more source
Non resolving pneumonia - A rare differential
Journal of Association of Pulmonologist of Tamil Nadu, 2020 Multiple myeloma(MM) is a malignant systemic hematological disease that arises from monoclonal plasma cells. It usually affects older patients and is characterized by the presence of monoclonal immunoproteins in the serum.
Monisha Anandhan +3 more
doaj +1 more source
Blood, 2014 ![Figure][1] A 32-year-old man with a history of severe mental retardation presented with a bulky 11.7 cm × 6.8 cm superior mediastinal mass, confluent 5.3 cm × 3.9 cm right hilar lymphadenopathy, and a cavitary right upper lobe lung mass. HIV serology was negative.
Armin, Rashidi, Stephen I, Fisher
openaire +3 more sources
Non-classical B Cell Memory of Allergic IgE Responses
Frontiers in Immunology, 2019 The long-term effectiveness of antibody responses relies on the development of humoral immune memory. Humoral immunity is maintained by long-lived plasma cells that secrete antigen-specific antibodies, and memory B cells that rapidly respond to antigen ...
Sean P. Saunders +5 more
doaj +1 more source
Blood Reviews, 2011 Plasma cell leukemia (PCL) is a rare, yet aggressive plasma cell (PC) neoplasm, variant of multiple myeloma (MM), characterized by high levels of PCs circulating in the peripheral blood. PCL can either originate de novo (primary PCL) or as a secondary leukemic transformation of MM (secondary PCL). Presenting signs and symptoms are similar to those seen
Flavio, Albarracin, Rafael, Fonseca
openaire +2 more sources
International Journal of General Medicine, 2023 Betty Agustina Tambunan,1– 3 I Dewa Gede Ugrasena,3,4 Aryati Aryati2,3 1Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; 2Department of Clinical Pathology, Faculty of Medicine, Universitas ...
Tambunan BA, Ugrasena IDG, Aryati A
doaj
Porto Biomedical Journal, 2016 Plasma cell leukaemia (PCL) is a rare and aggressive disease. Diagnosis is made when there are >2000/#mL circulating plasma cells in peripheral blood or plasmacytosis >20% of total leukocyte count. We report a case of a 51-year old man with generalized bone pain and constitutional symptoms.
Braga, Carlos Galvão +5 more
openaire +2 more sources
Plasma cell dyscrasias and normal plasma cells.
Journal of the Japan Society of the Reticuloendothelial System, 1993 We have recently shown that two-color analysis with fluorescein isothiocyanate (FITC)-anti-CD38 antibody could clearly distinguish myeloma cells (plasma cells) from other hematopoietic cells in the bone marrow. Myeloma cells (plasma cells) alone were located at CD38strong positive(+++) fractions.
Harada, Hironori, Kawano, Michio M.
openaire +2 more sources